7-Fluoro-1,2,3,4-tetrahydroquinolin-4-one, 98+%, 1g

(6-(ETHYLSULFONYL)PYRIDIN-3-YL)METHANAMINE HCL, 95.0%, 250mg

Dihydro-1H-cyclopenta[1,2-c:3,4-c']difuran-1,3,4,6(3aH,3bH,6aH)-tetraone, 95.0%, 25g

3-Methoxy-5-(trifluoromethyl)phenylboronic Acid (contains varying amounts of Anhydride)5g

Ethyl 1-methyl-3-(trifluoromethyl)pyrazole-4-carboxylate, 98.0%, 5g

cubeta prueba redonda NANOCOLOR® Hierro 3 + total

Dexamethasone palmitate, >98.0%, 500mg

Matraz receptor con revestimiento de PUR, 2000 ml, 1 pieza

(5-Cyclopropyloxazol-4-yl)methanamine hydrochloride, 97%, 500mg

(2S,4R)-Ethyl 5-([1,1'-biphenyl]-4-yl)-4-amino-2-methylpentanoate (Hydrochloride), 98%, 100mg

N-(4-METHOXYBENZYL)-N-METHYLMETHANESULFONAMIDE, 95.0%, 1g

1,8-diazabiciclo[5.4.0]undec-7-eno (DBU), mínimo 98 %, para síntesis, 25 ml, envase de vidrio

(S)-Pyrrolidin-3-ylmethanol, 95.0%, 1g